The One Big Beautiful Bill Act may offer some positives for health care in general and rheumatology specifically, according to Christina Downey, MD, chair of the American College of Rheumatology ...

The Food and Drug Administration will miss a deadline this week deciding whether to approve a drug for a potentially ...

Recursion Pharmaceuticals ( RXRX -5.13%) is not the most famous artificial intelligence (AI) stock on the market, but the ...

The Food and Drug Administration’s (FDA) approval of the first blood test to aid in the diagnosis of Alzheimer’s disease ...

Sun Pharma said the US FDA issued a Form-483 with eight observations after inspecting its Halol facility from June 2–13.

As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its jurisdiction. Some letters are not ...

The manipulated video of Tiangco reporting on the alleged anti-aging serum was posted by a fake Facebook page posing as ...

The Trump administration accuses Canada of not doing enough to stop flow of drugs into U.S., but Canadian border patrol ...

HUDCO, Manappuram Finance, Aditya Birla Fashion and Retail, Birlasoft, Central Depository Services, Chambal Fertilisers and ...

The share touched a 52-week high of Rs 960 and a 52-week low of Rs 598.55 on 02 December, 2024 and 09 May, 2025, respectively and trading 32.03 percent below its 52-week high and 9.01 percent above ...

India's AI-driven biomanufacturing potential, challenges, and the need for balanced regulations and accountability in a ...